SCLX Q2 2020 Earnings — Scilex Holding Company Revenue & Financial Results | Market Cap Arena

SCLXScilex Holding Company

$72M

Q2 2020 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$6M+12.0% YoY

Gross Profit

$5M90.9% margin

Operating Income

-$9M-149.7% margin

Net Income

-$12M-201.7% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$20M

Total Liabilities

$56M

Stockholders' Equity

-$35M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+12.0%
Gross Profit	$5M	$4M	+40.6%
Operating Income	-$9M	-$35M	+74.6%
Net Income	-$12M	-$45M	+73.4%